No Data
H.C. Wainwright Reaffirms Their Buy Rating on Acurx Pharmaceuticals (ACXP)
Promising Developments and Regulatory Milestones Justify Buy Rating for Acurx Pharmaceuticals
Insider Purchase: Director at $ACXP (ACXP) Buys 24,631 Shares
Express News | Acurx Pharmaceuticals CEO David Luci Reported Purchase Of 98,522 Shares @ Avg Price Of $0.51/Share In Form 4 Filing
Acurx Launches $2.5 Million Registered Direct Offering; Shares Fall After-Hours
Acurx Pharmaceuticals Reveals Purchase And Sale Of An Aggregate Of 2.46M Shares Of Its Common Stock At $1.015 Per Share
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}